Target Name: SEMG2
NCBI ID: G6407
Review Report on SEMG2 Target / Biomarker Content of Review Report on SEMG2 Target / Biomarker
SEMG2
Other Name(s): SEMG2_HUMAN | Semenogelin II | semenogelin 2 | SGII | Semenogelin-2 | semenogelin II | Semenogelin 2 | OTTHUMP00000031099

SEMG2: A Potential Drug Target for Muscle Health and Maintenance

SEMG2 (SEMG2_HUMAN) is a protein that is expressed in the human body and is known for its role in the development and maintenance of muscle mass and strength. It is also involved in the regulation of muscle function, which makes it an attractive drug target for researchers.

SEMG2 is a member of the SEMG family, which includes several similar proteins that are involved in the development and maintenance of muscle mass and strength. These proteins are known as myosin light chain kinases (MLCKs) and are critical for the regulation of muscle contraction and relaxation.

SEMG2 is expressed in a variety of tissues in the body, including muscle, heart, and brain. It is primarily localized to the muscle, where it plays a role in the regulation of muscle growth, differentiation, and function.

SEMG2 is involved in the regulation of several key processes that are involved in muscle development and maintenance. It is a critical regulator of muscle protein synthesis and degradation, which are important for muscle growth and maintenance. SEMG2 also plays a role in the regulation of muscle contractions, which are critical for movement and maintaining posture.

In addition to its role in muscle biology, SEMG2 is also involved in the regulation of several other processes in the body. It is a critical regulator of angiogenesis, which is the process by which new blood vessels are formed. SEMG2 is also involved in the regulation of inflammation, which is important for maintaining the health and function of the body.

SEMG2 is a potential drug target for several reasons. Firstly, it is involved in the regulation of key processes in the body that are important for maintaining the health and function of the body. Secondly, it is a critical regulator of muscle biology, which makes it an attractive target for drugs that are designed to improve muscle health and strength. Finally, SEMG2 is a versatile protein that can be targeted with a variety of different drug approaches, which makes it an attractive target for researchers who are looking for new treatments for a range of diseases.

Research into SEMG2 is still in its early stages, but it is clear that it has the potential to be a valuable drug target. Further studies are needed to fully understand its role in the regulation of muscle biology and to identify potential drug targets.

Protein Name: Semenogelin 2

Functions: Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa

The "SEMG2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEMG2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SENCR | SENP1 | SENP2 | SENP3 | SENP3-associated complex | SENP3-EIF4A1 | SENP5 | SENP6 | SENP7 | SENP8 | SEPHS1 | SEPHS1P4 | SEPHS1P6 | SEPHS2 | SEPSECS | SEPSECS-AS1 | SEPT5-GP1BB | SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4